Jump to content

Vizient Inc.

Search

Open menu

Log in
Register

Home
About
- Mission Statement
- Vizient, Inc. Accreditation
Plan a CE Activity
My account
Help
- Contact Us
- FAQs

You are here

Home » 2022 Stronger - PH415 - Reducing...

2022 Stronger - PH415 - Reducing Sugammadex Usage: Optimization of Use Criteria and Outcomes Evaluation - On Demand

Take Post-Test: PH415

Return to Course Home

Primary tabs

View (active tab)
Take

Take Post-Test: PH415

Questions	5
Available	Always
Pass rate	70 %
Backwards navigation	Allowed

You are not allowed to take this Post Test.

Course outline

Course progress

Not started
View Presentation
Open/Close details
- Required
Not started
Take Post-Test: PH415
Open/Close details
- Required
Not started
Complete Evaluation: PH415
Open/Close details
- Required
Not started
Claim Applicable CE Credit
Open/Close details
- Optional
Not started
Download CE Certificate
Open/Close details
- Optional

Expand / Minimize

Course navigation

You are not yet complete for this activity.

If you are attending a virtual event or viewing video content, you must meet the minimum participation requirement to proceed.

When the virtual event or video content is complete, please press "Next" again.

If you think this message was received in error, please contact an administrator.

Home	About us			Contact us
What we do	Newsroom			Subscription Manager
Our solutions	Blog			Privacy Policy and Legal Notice
Our network	Events			Frequently Asked Questions
Members	Careers
Suppliers

Powered by the EthosCE Learning Management System, a continuing education LMS.

Search

Primary tabs
View (active tab)

Take